Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids Article (Web of Science) Early Access (Web of Science)

Open Access

cited authors

  • Wynn, Daniel; Goldstick, Lawrence; Bauer, William; Zhao, Enxu; Tarau, Eva; Cohen, Jeffrey A.; Robertson, Derrick; Miller, Aaron

publication date

  • January 4, 2022


published in



  • Acthar Gel
  • clinical trial
  • multiple sclerosis
  • relapse
  • repository corticotropin injection